ATE262339T1 - Purinriboside als antiarrhythmika - Google Patents

Purinriboside als antiarrhythmika

Info

Publication number
ATE262339T1
ATE262339T1 AT01972964T AT01972964T ATE262339T1 AT E262339 T1 ATE262339 T1 AT E262339T1 AT 01972964 T AT01972964 T AT 01972964T AT 01972964 T AT01972964 T AT 01972964T AT E262339 T1 ATE262339 T1 AT E262339T1
Authority
AT
Austria
Prior art keywords
purinribosides
antiarrhythmics
mammals
administering
formula
Prior art date
Application number
AT01972964T
Other languages
English (en)
Inventor
Andrew A Wolff
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Application granted granted Critical
Publication of ATE262339T1 publication Critical patent/ATE262339T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
AT01972964T 2000-09-08 2001-09-07 Purinriboside als antiarrhythmika ATE262339T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23101100P 2000-09-08 2000-09-08
US30532801P 2001-07-13 2001-07-13
PCT/US2001/028143 WO2002020024A1 (en) 2000-09-08 2001-09-07 Purine ribosides as antiarrhythmics

Publications (1)

Publication Number Publication Date
ATE262339T1 true ATE262339T1 (de) 2004-04-15

Family

ID=26924751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972964T ATE262339T1 (de) 2000-09-08 2001-09-07 Purinriboside als antiarrhythmika

Country Status (17)

Country Link
US (1) US6537974B2 (de)
EP (1) EP1315508B1 (de)
JP (2) JP2004508336A (de)
KR (1) KR20030040443A (de)
CN (1) CN1482913A (de)
AT (1) ATE262339T1 (de)
AU (2) AU2001292591B2 (de)
CA (1) CA2421738C (de)
DE (1) DE60102481T2 (de)
ES (1) ES2215146T3 (de)
HU (1) HUP0302685A3 (de)
IL (2) IL154652A0 (de)
MX (1) MXPA03001741A (de)
NO (1) NO20030852D0 (de)
NZ (1) NZ524390A (de)
PL (1) PL205874B1 (de)
WO (1) WO2002020024A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646142A (zh) * 2002-04-18 2005-07-27 Cv医药有限公司 包括给予A1腺苷激动剂以及β受体阻滞剂、钙通道阻滞剂、或强心苷的治疗心律失常的方法
US7902088B2 (en) 2004-03-15 2011-03-08 Sharp Laboratories Of America, Inc. High quantum efficiency silicon nanoparticle embedded SiOXNY luminescence device
WO2006040765A1 (en) * 2004-10-12 2006-04-20 Closed Loop Therapies Ltd. Methods and implantable devices for treating supraventricular arrhythmias

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US4980379A (en) * 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
WO1995011940A1 (fr) * 1993-10-29 1995-05-04 Daikin Industries, Ltd. Composition de resine thermoplastique et stratifie a base de cette composition
AU4070597A (en) * 1996-08-16 1998-03-06 The Texas A & M University System Modifying insect cell gylcosylation pathways with baculovirus expression vectors
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives

Also Published As

Publication number Publication date
MXPA03001741A (es) 2004-09-10
DE60102481T2 (de) 2005-02-24
NO20030852L (no) 2003-02-24
US20020055485A1 (en) 2002-05-09
IL154652A0 (en) 2003-09-17
JP2004508336A (ja) 2004-03-18
DE60102481D1 (en) 2004-04-29
NO20030852D0 (no) 2003-02-24
KR20030040443A (ko) 2003-05-22
NZ524390A (en) 2005-02-25
PL205874B1 (pl) 2010-06-30
HUP0302685A2 (hu) 2003-12-29
AU9259101A (en) 2002-03-22
AU2001292591B2 (en) 2004-06-03
PL360582A1 (en) 2004-09-06
CA2421738C (en) 2009-03-24
EP1315508A1 (de) 2003-06-04
CN1482913A (zh) 2004-03-17
JP2008255118A (ja) 2008-10-23
HUP0302685A3 (en) 2005-02-28
EP1315508B1 (de) 2004-03-24
US6537974B2 (en) 2003-03-25
WO2002020024A1 (en) 2002-03-14
CA2421738A1 (en) 2002-03-14
ES2215146T3 (es) 2004-10-01
IL154652A (en) 2008-11-26

Similar Documents

Publication Publication Date Title
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
ATE302205T1 (de) Thieno- und furopyrimidin derivate als a2a- rezeptor antagonisten
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
TR200102800T2 (tr) Yeni bileşikler.
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
SV2002000097A (es) Inhibidores de metaloproteasas ref.pcs10322/82940 /bb
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
BR9810342A (pt) Novos compostos imidazola substituìdos
DE60122337D1 (de) Verwendung von taci als antitumormittel
BR0007864A (pt) Composto, e, uso de um composto
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA200400208A1 (ru) Фенилацетамидотиазольные производные, способ их получения и их использования в качестве противоопухолевых средств
IL135825A0 (en) Use of mirtazapine for treating sleep apneas
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DE60112960D1 (de) Kondensierte pyridoindolderivate
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
NO20010654D0 (no) Ny anvendelse av taxoidderivater
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
ATE262339T1 (de) Purinriboside als antiarrhythmika
ATE293111T1 (de) Kondensierte pyrazindionderivate als pde inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties